Admirable but a shame too
@bcr. I certainly would have been tempted to sell some at $1.50 and earlier no doubt, if I were a long-term holder. No reason you might not get another opportunity in a year or so IMO, if John's early Indo approval at 9 months interim data inference comes to fruition.
I am telling you how to suck eggs but Indonesia probably has more then 15 million people living with diabetes, with a reported prevalence rate of 6.2%. This is an easy fix for DFU's that probably occur in another 6% of that 6%. That's a million punters at least - probably higher, prevalence of DFU's in less developed countries well above global prevalence of course.
Good luck to all holders. Hopefully the company soon achieves the beginnings of commercial pathways its been promising for some time now. As a bonus to making investors money, we might all see a few less Indonesians sans a foot on any indulgent holiday from the profits.
(20min delay)